146 related articles for article (PubMed ID: 37424322)
1. Integrated genomic and single-cell transcriptomic analyses reveal clonal evolution and immune signature in donor cell leukemia after haploidentical allogeneic hematopoietic stem cell transplantation.
Chen H; Zhao X; Pan W; Xiao H
Leuk Lymphoma; 2023 Oct; 64(10):1681-1688. PubMed ID: 37424322
[TBL] [Abstract][Full Text] [Related]
2. Clonal evolution including partial loss of human leukocyte antigen genes favoring extramedullary acute myeloid leukemia relapse after matched related allogeneic hematopoietic stem cell transplantation.
Stölzel F; Hackmann K; Kuithan F; Mohr B; Füssel M; Oelschlägel U; Thiede C; Röllig C; Platzbecker U; Schetelig J; Illmer T; Schaich M; Seliger B; Hartmann A; Baretton G; Zietz C; Ehninger G; Schrock E; Bornhäuser M
Transplantation; 2012 Apr; 93(7):744-9. PubMed ID: 22314337
[TBL] [Abstract][Full Text] [Related]
3. Comprehensive genetic analysis of donor cell derived leukemia with KMT2A rearrangement.
Taniguchi R; Muramatsu H; Okuno Y; Suzuki K; Obu S; Nakatochi M; Shimamura T; Takahashi Y; Horikoshi Y; Watanabe K; Kojima S
Pediatr Blood Cancer; 2018 Feb; 65(2):. PubMed ID: 28921816
[TBL] [Abstract][Full Text] [Related]
4. Donor cell-derived acute promyelocytic leukemia after allogeneic hematopoietic stem cell transplantation.
Bouvier A; Ribourtout B; François S; Orvain C; Paz DL; Beucher A; Guérard A; Guardiola P; Ugo V; Blanchet O; Geneviève F; Schmidt A; Hunault-Berger M
Eur J Haematol; 2018 Oct; 101(4):570-574. PubMed ID: 30007088
[TBL] [Abstract][Full Text] [Related]
5. [Donor cell-derived hematological malignancies after allogeneic hematopoietic stem cell transplantation].
Kato M
Rinsho Ketsueki; 2017; 58(7):813-817. PubMed ID: 28781279
[TBL] [Abstract][Full Text] [Related]
6. Donor Clonal Hematopoiesis and Recipient Outcomes After Transplantation.
Gibson CJ; Kim HT; Zhao L; Murdock HM; Hambley B; Ogata A; Madero-Marroquin R; Wang S; Green L; Fleharty M; Dougan T; Cheng CA; Blumenstiel B; Cibulskis C; Tsuji J; Duran M; Gocke CD; Antin JH; Nikiforow S; DeZern AE; Chen YB; Ho VT; Jones RJ; Lennon NJ; Walt DR; Ritz J; Soiffer RJ; Gondek LP; Lindsley RC
J Clin Oncol; 2022 Jan; 40(2):189-201. PubMed ID: 34793200
[TBL] [Abstract][Full Text] [Related]
7. Synchronous development of acute myeloid leukemia in recipient and donor after allogeneic bone marrow transplantation: report of a case with comments on donor evaluation.
Glasser L; Meloni-Ehrig A; Greaves W; Demel KC; Butera J
Transfusion; 2009 Mar; 49(3):555-62. PubMed ID: 19040490
[TBL] [Abstract][Full Text] [Related]
8. True Donor Cell Leukemia after Allogeneic Hematopoietic Stem Cell Transplantation: Diagnostic and Therapeutic Considerations-Brief Report.
Hoffmann M; Banz Y; Halter J; Schoumans J; Tchinda J; Bacher U; Pabst T
Curr Oncol; 2024 Apr; 31(4):2067-2075. PubMed ID: 38668056
[TBL] [Abstract][Full Text] [Related]
9. Donor cell leukemia: a review.
Wiseman DH
Biol Blood Marrow Transplant; 2011 Jun; 17(6):771-89. PubMed ID: 20951819
[TBL] [Abstract][Full Text] [Related]
10. Donor cell leukemia/myelodysplastic syndrome after allogeneic stem cell transplantation: a rare phenomenon with more challenges for hematologists.
Zhang S; Li L; Cao W; Li Y; Jiang Z; Yu J; Wan D
Hematology; 2021 Dec; 26(1):648-651. PubMed ID: 34474660
[TBL] [Abstract][Full Text] [Related]
11. Donor cell leukemia: insight into cancer stem cells and the stem cell niche.
Flynn CM; Kaufman DS
Blood; 2007 Apr; 109(7):2688-92. PubMed ID: 17132724
[TBL] [Abstract][Full Text] [Related]
12. [Prediction of T-cell immune reconstitution by investigating T cell receptor excision circle and T-cell receptor beta-chain variable region clonal repertoire in leukemia patients after allogeneic hematopoietic stem cell transplantation].
Fu YW; Wu DP; Cen JN; Feng YF; Chang WR; Qiu QC; Zhu ZL; Zhu P
Zhonghua Yi Xue Za Zhi; 2007 Aug; 87(32):2265-7. PubMed ID: 18001548
[TBL] [Abstract][Full Text] [Related]
13. Epigenetic dysregulation of hematopoietic stem cells and preleukemic state.
Kunimoto H; Nakajima H
Int J Hematol; 2017 Jul; 106(1):34-44. PubMed ID: 28555413
[TBL] [Abstract][Full Text] [Related]
14. Generation of donor-derived Wilms tumor antigen 1-specific cytotoxic T lymphocytes with potent anti-leukemia activity for somatic cell therapy in children given haploidentical stem cell transplantation: a feasibility pre-clinical study.
Ferulli F; Tanzi M; Turin I; Montini E; Rosti V; Acquafredda G; Lisini D; Compagno F; Boghen S; Licari A; Marseglia G; Zecca M; Montagna D
Cytotherapy; 2019 Sep; 21(9):958-972. PubMed ID: 31279696
[TBL] [Abstract][Full Text] [Related]
15. Role of Donor Clonal Hematopoiesis in Allogeneic Hematopoietic Stem-Cell Transplantation.
Frick M; Chan W; Arends CM; Hablesreiter R; Halik A; Heuser M; Michonneau D; Blau O; Hoyer K; Christen F; Galan-Sousa J; Noerenberg D; Wais V; Stadler M; Yoshida K; Schetelig J; Schuler E; Thol F; Clappier E; Christopeit M; Ayuk F; Bornhäuser M; Blau IW; Ogawa S; Zemojtel T; Gerbitz A; Wagner EM; Spriewald BM; Schrezenmeier H; Kuchenbauer F; Kobbe G; Wiesneth M; Koldehoff M; Socié G; Kroeger N; Bullinger L; Thiede C; Damm F
J Clin Oncol; 2019 Feb; 37(5):375-385. PubMed ID: 30403573
[TBL] [Abstract][Full Text] [Related]
16. Development of leukemia in donor cells after allogeneic stem cell transplantation--a survey of the European Group for Blood and Marrow Transplantation (EBMT).
Hertenstein B; Hambach L; Bacigalupo A; Schmitz N; McCann S; Slavin S; Gratwohl A; Ferrant A; Elmaagacli A; Schwertfeger R; Locasciulli A; Zander A; Bornhäuser M; Niederwieser D; Ruutu T;
Haematologica; 2005 Jul; 90(7):969-75. PubMed ID: 15996934
[TBL] [Abstract][Full Text] [Related]
17. Donor CMV-specific cytotoxic T lymphocytes successfully treated drug-resistant cytomegalovirus encephalitis after allogeneic hematopoietic stem cell transplantation.
Ke P; Bao X; Zhou J; Li X; Zhuang J; He X; Wu D; Zhang X; Ma X
Hematology; 2020 Dec; 25(1):43-47. PubMed ID: 31906810
[No Abstract] [Full Text] [Related]
18. Clonal hematopoiesis in donors and long-term survivors of related allogeneic hematopoietic stem cell transplantation.
Boettcher S; Wilk CM; Singer J; Beier F; Burcklen E; Beisel C; Ventura Ferreira MS; Gourri E; Gassner C; Frey BM; Schanz U; Skoda RC; Ebert BL; Brummendorf TH; Beerenwinkel N; Manz MG
Blood; 2020 Apr; 135(18):1548-1559. PubMed ID: 32181816
[TBL] [Abstract][Full Text] [Related]
19. Engrafted Donor-Derived Clonal Hematopoiesis after Allogenic Hematopoietic Cell Transplantation is Associated with Chronic Graft-versus-Host Disease Requiring Immunosuppressive Therapy, but no Adverse Impact on Overall Survival or Relapse.
Newell LF; Williams T; Liu J; Yu Y; Chen Y; Booth GC; Knight RJ; Goslee KR; Cook RJ; Leonard J; Meyers G; Traer E; Press RD; Fan G; Wang Y; Raess PW; Maziarz RT; Dunlap J
Transplant Cell Ther; 2021 Aug; 27(8):662.e1-662.e9. PubMed ID: 33901720
[TBL] [Abstract][Full Text] [Related]
20. Clonal hematopoiesis in hematopoietic stem cell transplantation.
Wilk CM; Manz MG; Boettcher S
Curr Opin Hematol; 2021 Mar; 28(2):94-100. PubMed ID: 33394723
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
